Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 394 (RNA5SP394) is classified as a **pseudogene**—a genomic DNA sequence similar to a normal gene but non-functional; it typically does not encode a functional product[1][2]. It is part of a large family of 5S ribosomal RNA pseudogenes in the human genome. Functional 5S ribosomal RNA (5S rRNA) is a structural and regulatory RNA essential for ribosome assembly and function, but pseudogenes such as RNA5SP394 are generally considered non-coding and non-functional[3][5]. They may occasionally be transcribed, but do not produce active 5S rRNA or participate in ribosome assembly or translation. Pseudogene expression patterns have been associated with tumor subtypes and prognosis in some cancers, potentially reflecting broader molecular changes, but there is no established evidence that RNA5SP394 itself is an actionable therapeutic target or clinically relevant biomarker[4]. No drugs are known to target this pseudogene, and it does not have a defined role in disease pathology or therapy. **Notes:** - The entry is **not a druggable target, receptor, enzyme, or similar molecule** relevant to therapy, but rather a non-functional genetic locus[1]. - No known mechanism of action, interacting drugs, or therapeutic safety implications are associated with this pseudogene. **Interpretation accuracy and errors:** The query refers to a **pseudogene**, not a protein-coding gene, functional RNA, or therapeutic target. Therefore, most typical target-centric information (such as classification as a receptor, family, disease role, drug interaction, etc.) does not apply to this entry[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 394 (RNA5SP394).